Shares

17 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 14, 2024

SELL
$11.67 - $20.73 $2.81 Million - $4.99 Million
-240,800 Reduced 93.33%
17,200 $278,000
Q3 2023

Nov 14, 2023

SELL
$12.15 - $17.85 $3.93 Million - $5.78 Million
-323,800 Reduced 55.65%
258,000 $3.17 Million
Q2 2023

Aug 14, 2023

SELL
$14.1 - $19.83 $924,960 - $1.3 Million
-65,600 Reduced 10.13%
581,800 $9.35 Million
Q1 2023

May 15, 2023

SELL
$9.09 - $19.45 $1.7 Million - $3.63 Million
-186,800 Reduced 22.39%
647,400 $11.3 Million
Q4 2022

Feb 14, 2023

SELL
$6.45 - $12.07 $1.34 Million - $2.52 Million
-208,500 Reduced 20.0%
834,200 $7.71 Million
Q3 2022

Nov 14, 2022

SELL
$7.86 - $12.91 $1.13 Million - $1.85 Million
-143,200 Reduced 12.08%
1,042,700 $8.98 Million
Q2 2022

Aug 15, 2022

BUY
$7.06 - $13.97 $6.99 Million - $13.8 Million
989,800 Added 504.74%
1,185,900 $9.67 Million
Q1 2022

May 16, 2022

BUY
$12.15 - $35.28 $2.38 Million - $6.92 Million
196,100 New
196,100 $2.38 Million
Q4 2021

Feb 14, 2022

SELL
$30.49 - $48.49 $213,430 - $339,430
-7,000 Closed
0 $0
Q3 2021

Nov 15, 2021

BUY
$41.66 - $52.52 $291,620 - $367,640
7,000 New
7,000 $338,000
Q4 2019

Feb 14, 2020

SELL
$18.96 - $29.84 $316,632 - $498,328
-16,700 Closed
0 $0
Q3 2019

Nov 14, 2019

SELL
$19.12 - $26.24 $954,088 - $1.31 Million
-49,900 Reduced 74.92%
16,700 $319,000
Q2 2019

Aug 14, 2019

SELL
$19.57 - $24.1 $782,800 - $964,000
-40,000 Reduced 37.52%
66,600 $1.46 Million
Q1 2019

May 15, 2019

SELL
$12.14 - $20.46 $302,286 - $509,454
-24,900 Reduced 18.94%
106,600 $2.18 Million
Q4 2018

Feb 14, 2019

SELL
$11.24 - $18.5 $186,584 - $307,100
-16,600 Reduced 11.21%
131,500 $1.66 Million
Q3 2018

Nov 14, 2018

BUY
$12.5 - $15.38 $1.15 Million - $1.42 Million
92,200 Added 164.94%
148,100 $2.27 Million
Q2 2018

Aug 14, 2018

BUY
$7.99 - $14.05 $446,641 - $785,395
55,900 New
55,900 $733,000

Others Institutions Holding NEO

About NEOGENOMICS INC


  • Ticker NEO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 125,796,000
  • Market Cap $2.16B
  • Description
  • NeoGenomics, Inc. operates a network of cancer-focused testing laboratories in the United States, Europe, and Asia. It operates through, Clinical Services and Pharma Services segments. The company offers testing services to hospitals, reference labs, pathologists, oncologists, clinicians, pharmaceutical firms, and researchers. It provides cytoge...
More about NEO
Track David A. Siegel's Portfolio

Track David A. Siegel Portfolio

Follow David A. Siegel (Two Sigma Advisers, LP) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Two Sigma Advisers, LP, based on Form 13F filings with the SEC.

News

Stay updated on Two Sigma Advisers, LP and David A. Siegel with notifications on news.